Canal Capital Management, LLC Gilead Sciences, Inc. Transaction History

Canal Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $602,796 - $786,603	-9,957 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$71.28 - $78.92 $4,847 - $5,366	-68 Reduced 0.68%	9,957 $769,000
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $19,139 - $22,325	295 Added 3.03%	10,025 $710,000
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $129,436 - $157,797	-1,777 Reduced 15.44%	9,730 $734,000
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $200,216 - $235,025	2,814 Added 32.37%	11,507 $824,000
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $626,852 - $742,990	8,693	8,693 $704,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Canal Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Canal Capital Management, LLC with notifications on news.